Visit COVID-19 resources

[Skip to Content]

Short-term effects of intravitreal ranibizumab and bevacizumab administration on 24-h ambulatory blood pressure monitoring recordings in normotensive patients with age-related macular degeneration – (Eye 31, 677 (May 2017))

11 May 2017

This news item is available to RCOphth members only, please log in below to access.

Members Login